The Yoshiji Lab at McGill University is recruiting a fully funded Postdoctoral Fellow to lead projects at the intersection of human genetics, proteomics, and multi-omics for drug target discovery and precision medicine in cardiometabolic diseases and beyond.
The successful candidate will analyze biobank-scale datasets — including UK Biobank (~500,000 participants), NIH All of Us (~440,000), the Canadian Longitudinal Study on Aging (CLSA, ~26,000), and the McGill-based BioPortal, which the Yoshiji Lab co-leads (~3,000 participants with ~5,400 plasma protein measurements) — to identify and characterize causal proteins and genetic variants that can be translated into therapeutic targets.
The Fellow will join a vibrant and growing team (5 PhD students, 1 MSc student, 1 visiting professor, and 1 visiting graduate trainee) and contribute to active international collaborations, including with the Broad Institute / Harvard, UCSD, Stanford, Kyoto University, Uppsala University, and the Type 2 Diabetes Global Genetics Consortium.
Representative lab work includes the lab’s recent Nature Genetics publication on proteome-wide Mendelian randomization and proteome-phenome mapping